tiprankstipranks
Qualigen Therapeutics Granted Nasdaq Listing Extension
Company Announcements

Qualigen Therapeutics Granted Nasdaq Listing Extension

Pick the best stocks and maximize your portfolio:

Qualigen Therapeutics ( (QLGN) ) has provided an announcement.

Qualigen Therapeutics, Inc. has been granted an extension by the Nasdaq Hearings Panel to continue its listing, with a compliance deadline set for November 19, 2024. The company is actively working towards meeting the necessary criteria for its continued presence on The Nasdaq Capital Market. This news, which reflects the company’s current efforts and the potential implications for its future, is vital for investors tracking Qualigen’s compliance journey and its impact on stock performance.

Find detailed analytics on QLGN stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyQualigen Therapeutics regains compliance with Nasdaq’s min bid price
TheFlyQualigen announces $4.5M private placement of Preferred Shares
TipRanks Auto-Generated NewsdeskQualigen Therapeutics Appoints Graydon Bensler to Board
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App